Cargando…
Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling
BACKGROUND: There are seven insulin-like growth factor binding proteins (IGFBPs) that bind insulin-like growth factors (IGFs). IGFBP like protein1 (IGFBPL1) is a new member of this family. The function and mechanism of IGFBPL1 in esophageal cancer remains to be elucidated. METHODS: Eight esophageal...
Autores principales: | Liu, Yingge, Zhang, Meiying, He, Tao, Yang, Weili, Wang, Lidong, Zhang, Lirong, Guo, Mingzhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011530/ https://www.ncbi.nlm.nih.gov/pubmed/32041673 http://dx.doi.org/10.1186/s13148-020-0815-x |
Ejemplares similares
-
Epigenetic silencing of JAM3 promotes esophageal cancer development by activating Wnt signaling
por: Yang, Weili, et al.
Publicado: (2022) -
Methylation of NRN1 is a novel synthetic lethal marker of PI3K‐Akt‐mTOR and ATR inhibitors in esophageal cancer
por: Du, Wushuang, et al.
Publicado: (2021) -
IGFBPL1 Regulates Axon Growth through IGF-1-mediated Signaling Cascades
por: Guo, Chenying, et al.
Publicado: (2018) -
Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth
por: Dong, Yan, et al.
Publicado: (2015) -
Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development
por: Wang, Ying, et al.
Publicado: (2017)